RedHill Biopharma Further Expands Opaganib Manufacturing Capac...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
TEL AVIV, Israel and RALEIGH, N.C., Jan 28 2021 /PRNewswire-AsiaNet/ -- New agreement further expands manufacturing capacity for orally-administered opaganib following positive top-line data from its Phase 2 COVID-19 study, progress with the ongoing global Phase 2/3 study, and amid the urgent need to address emerging ...
Authors: LATEST ASIANET NEWS RELEASES